Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie V. Avila, Thierry Iraguha, Philip Margiotta, Kim G. Hankey, Patricia Lesho, Jennie Y. Law, Seung Tae Lee, John W. Baddley, Mehmet H. Kocoglu, Jean A. Yared, Nancy M. Hardy, Aaron P. Rapoport, Djordje Atanackovic
Topics & Concepts
CD19Coronavirus disease 2019 (COVID-19)Immune systemImmunologyMedicineVaccination2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCell therapyT cellCellImmunotherapyB cellAntibodyBiologyInternal medicineOutbreakGeneticsDiseaseInfectious disease (medical specialty)CAR-T cell therapy researchCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 Research